4SC Gives Update on the Clinical Development of its Lead Cancer Compound Resminostat

News   May 30, 2013

 
4SC Gives Update on the Clinical Development of its Lead Cancer Compound Resminostat
 
 
 

RELATED ARTICLES

Tuberculosis Vaccine Trial Results Offer Potential for BCG Revaccination

News

The study is the first 'prevention of infection' trial conducted for tuberculosis, the world's leading infectious disease killer.

READ MORE

Duplicate Genes Offer a Explanation for Differences Between the Sexes

News

A study in flies has identified the process by duplicating a gene can help resolve genetic sexual conflict.

READ MORE

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE